Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3111

Anticoagulant Drugs Market by Type (Unfractionated Heparin, Warfarin, Low Molecular Weight Heparin, Factor Xa Inhibitors and Direct Inhibition Inhibitors) and Geography - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI 171673
Pages: NA
Apr 2018 | 1180 Views
face gplus_n
Author's : NA
Tables: NA
Charts: NA
twit_n pr_n

Blood normally flows through arteries and veins in the circulatory system, but clot formation can block the flow of blood, which results in thrombosis. Clot formation in blood vessels is primarily the reason of various diseases that include heart attack, stroke, and venous thrombosis. Thus, antithrombotic drugs are used to reduce the formation of blood clots. These drugs can be categorized into two classes - anticoagulant and antiplatelet drugs. Anti-coagulant drugs reduce fibrin formation thereby slowing down the process of clotting, whereas antiplatelet drugs prevent clot formation by inhibiting platelet clumping.
The growth of world anticoagulant drugs market is supported by a number of factors such as rise in incidence of cardiovascular diseases, increase in ageing population, obesity related issues, and increased healthcare expenditure. Despite the availability of antithrombotic drugs to counteract and treat arterial and venous thrombosis, the illness still stays as one of the major reason of death and disability worldwide. This shows that the present medications available are not efficient to combat this disorder. Thus, there is huge potential for the market to grow and develop. However, patent expiration of drugs, stringent regulations by government and side effects of drugs such as head ache are expected to restrain growth of the market.

The report segments the anticoagulant drugs market on the basis of type and geography. According to the anticoagulants type, the market is segmented into unfractionated heparin, warfarin, low molecular weight heparin, factor Xa inhibitors, direct inhibition inhibitors, and others. Geographical breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.

Key players adopt product launch as their key strategy. Xarelto, product of Jannsen pharmaceuticals received FDA approval in June 2013. The drug helps prevent the risk of stent thrombosis in patients with acute coronary syndrome. In addition, Pradaxa (April, 2013) is used to reduce the risk of stroke and blood clotting in Artrial Fibrillation patients.

The key companies that operate in the global anticoagulant drugs market include Sanofi, Bristol-Myers Squibb, Jansen pharmaceuticals, Boehringer Ingelheim, Johnson & Johnson, and Bayer.

KEY MARKET BENEFITS:

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global anticoagulant drugs market.
  • In-depth analysis is conducted by constructing market estimations for the key market segments between 2014 and 2022.
  • Geographically, therapies for anti-coagulant drugs market is analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA.
  • This study evaluates competitive landscape and value chain to predict the competitive environment across the geographies.
  • Comprehensive analysis of factors that drive and restrict the growth of the global anti-coagulant drugs market is provided.

ANTICOAGULANT DRUGS MARKETKEY SEGMENTS:

Market by Type

  • Unfractionated Heparin
  • Warfarin
  • Low Molecular Weight Heparin
  • Factor XA Inhibitors
  • Direct Inhibition Inhibitors
  • Others

Market by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Others
  • Asia-Pacific
    • Japan
    • China
    • India
    • Others
  • LAMEA
    • Brazil
    • UAE
    • Africa
    • Others
 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, Please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts